BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29720491)

  • 1. Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.
    Humbert O; Chan F; Rajawat YS; Torgerson TR; Burtner CR; Hubbard NW; Humphrys D; Norgaard ZK; O'Donnell P; Adair JE; Trobridge GD; Scharenberg AM; Felsburg PJ; Rawlings DJ; Kiem HP
    Blood Adv; 2018 May; 2(9):987-999. PubMed ID: 29720491
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Rajawat YS; Humbert O; Cook SM; Radtke S; Pande D; Enstrom M; Wohlfahrt ME; Kiem HP
    Hum Gene Ther; 2021 Jan; 32(1-2):113-127. PubMed ID: 32741228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant mobilization with granulocyte colony-stimulating factor improves B-cell reconstitution by lentiviral vector gene therapy in SCID-X1 mice.
    Huston MW; Riegman AR; Yadak R; van Helsdingen Y; de Boer H; van Til NP; Wagemaker G
    Hum Gene Ther; 2014 Oct; 25(10):905-14. PubMed ID: 25222508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous injection of a foamy virus vector to correct canine SCID-X1.
    Burtner CR; Beard BC; Kennedy DR; Wohlfahrt ME; Adair JE; Trobridge GD; Scharenberg AM; Torgerson TR; Rawlings DJ; Felsburg PJ; Kiem HP
    Blood; 2014 Jun; 123(23):3578-84. PubMed ID: 24642749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
    Horino S; Uchiyama T; So T; Nagashima H; Sun SL; Sato M; Asao A; Haji Y; Sasahara Y; Candotti F; Tsuchiya S; Kure S; Sugamura K; Ishii N
    PLoS One; 2013; 8(8):e71594. PubMed ID: 23990961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Vivo Gene Therapy with Foamy Virus Vectors.
    Rajawat YS; Humbert O; Kiem HP
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of the mobilization with AMD3100, granulocyte-colony-stimulating factor (G-CSF) alone and in combination on the immunological function of the lymphocytes in mice].
    Kong Y; Feng R; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):358-61. PubMed ID: 22781791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
    Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
    N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
    Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
    Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of G-CSF and AMD3100 mobilizes bone marrow-derived stem cells to protect against cisplatin-induced acute kidney injury in mice.
    Chen Z; Ren X; Ren R; Wang Y; Shang J
    Stem Cell Res Ther; 2021 Mar; 12(1):209. PubMed ID: 33761993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.
    Di Giacomo F; Lewandowski D; Cabannes E; Nancy-Portebois V; Petitou M; Fichelson S; Romeo PH
    Haematologica; 2012 Apr; 97(4):491-9. PubMed ID: 22180429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.
    Trobridge GD; Beard BC; Wu RA; Ironside C; Malik P; Kiem HP
    PLoS One; 2012; 7(9):e45173. PubMed ID: 23028826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.
    Girbl T; Lunzer V; Greil R; Namberger K; Hartmann TN
    Transfusion; 2014 Sep; 54(9):2325-35. PubMed ID: 24673458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice.
    Li C; Goncalves KA; Raskó T; Pande A; Gil S; Liu Z; Izsvák Z; Papayannopoulou T; Davis JC; Kiem HP; Lieber A
    Blood Adv; 2021 Mar; 5(5):1239-1249. PubMed ID: 33646305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.
    De Ravin SS; Wu X; Moir S; Anaya-O'Brien S; Kwatemaa N; Littel P; Theobald N; Choi U; Su L; Marquesen M; Hilligoss D; Lee J; Buckner CM; Zarember KA; O'Connor G; McVicar D; Kuhns D; Throm RE; Zhou S; Notarangelo LD; Hanson IC; Cowan MJ; Kang E; Hadigan C; Meagher M; Gray JT; Sorrentino BP; Malech HL; Kardava L
    Sci Transl Med; 2016 Apr; 8(335):335ra57. PubMed ID: 27099176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10.
    MacDonald KP; Le Texier L; Zhang P; Morris H; Kuns RD; Lineburg KE; Leveque L; Don AL; Markey KA; Vuckovic S; Bagger FO; Boyle GM; Blazar BR; Hill GR
    J Immunol; 2014 Apr; 192(7):3180-9. PubMed ID: 24585878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study.
    Fruehauf S; Veldwijk MR; Seeger T; Schubert M; Laufs S; Topaly J; Wuchter P; Dillmann F; Eckstein V; Wenz F; Goldschmidt H; Ho AD; Calandra G
    Cytotherapy; 2009; 11(8):992-1001. PubMed ID: 19929463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Acting IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Granulocyte Colony-Stimulating Factor or AMD3100.
    Alt C; Yuan S; Wu F; Stankovich B; Calaoagan J; Schopies S; Wu JY; Shen J; Schneider D; Zhu Y; Zhao XY; Lippow SM; Bauzon M
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1475-1485. PubMed ID: 31163266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.